Tina Williamson, Director of Corporate Compliance for Mississippi Children’s Home Services, shares tips and advice for those transitioning from the clinical field into healthcare compliance; namely, leveraging clinical experience for compliance success.
Business ethics education is a necessary component of any corporate compliance training initiative and will lead to long-term success for organizations.
Conselium, the official sponsor of CCI, is representing a Healthcare Services provider experiencing one year revenue growth of 10% and cumulative seven year revenue growth of 220%. They are looking to fill an opening for Director of Privacy.
According to Matt Vogelien, New York’s Mandatory Medicaid Compliance Program requirements represent a significant step in the potential transition toward mandatory compliance programs for healthcare organizations.
Collen Faddick and Gina Kastel from Faegre & Benson discuss specific examples of enhanced transparency expectations and the factors that contribute to them, and conclude with suggestions for compliance professionals to adapt to these changes.
Morgan Ryan of Dallas-based insurance agency SIG Insurance Professionals provides a few key points regarding compliance with the recently passed health care reform bill.
This article, by Kenneth Yood and Christine Cohn of Sheppard Mullin, presents a summary of some of the key features in Senator Baucus’ health care bill that are particularly relevant to the drug industry and that merit close attention.
Anyone doubting the commitment of business to compliance and ethics will be surprised by the findings of a survey by the SCCE and HCCA which reveals spending on compliance has remained stronger than anticipated. Roughly three out of four companies either kept compliance spending even or actually increased it in 2009, and for 2010 the prognosis is even brighter.
The Advanced Medical Technology Association recently publicly recognized early adopters of the revised AdvaMed Code of Ethics on Interactions with Health Care Professionals.
On Christmas Eve it was announced that Boston Scientific has agreed to pay $22 million as it settles claims that one of its divisions gave kickbacks to doctors.
